Shares of Novo Nordisk A/S took a dive in early Monday trading after the drugmaker said oral semaglutide, which is the key ingredient in the company's Ozempic and Wegovy diabetes and weight-loss drugs ...

Stock futures pointed higher Monday to begin a holiday-shortened week, with investors increasingly confident the Federal Reserve will cut interest rates at its December meeting.

Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...

The domestic equity benchmarks slipped for a second straight session as profit booking and caution ahead of the US Feds December policy outlook kept sentiment muted. Traders also stayed guarded amid ...

Novo Nordisk stock dropped 9% as it said its trial of its weight-loss drug to treat Alzheimer's didn't show a delay in disease progress. Biogen, which sells an Alzheimer drug, rose 5%. Alphabet stock ...

S&P 500 is up 12.3% in 2025 and the Nasdaq is up 15.3% through Nov. 21. Both beat their long-term 10% average. A 10-year ...

The stock market needs to show a lot of strength after damaging recent losses. Watch Nvidia, Apple and Eli Lilly.

We will all die one day, but can we just stop living?' 'Join markets anyway, at least through a passive fund.’ ‘Everything is ...

U.S. stock index struggled last week, with the S&P 500 slipping 2%, bringing its November decline to 3.5%. The tech-heavy NASDAQ Composite shed 2.7% in the prior week and is down 6.1% for the month, ...

Stock futures climbed early Monday as Thanksgiving week began with cautious optimism. Nasdaq 100 futures rose 0.99%, S&P 500 ...

US stock futures mostly rose on Monday, heading into the shortened Thanksgiving trading week buoyed by hopes for an interest-rate cut and eyeing a further rebound from a pullback that has cooled this ...

Here's a closer look at three Dow stocks that could soar in 2026, and then keep soaring after that. Image source: Getty ...